Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease

Autor: Gareb, Bahez, Beugeling, Max, Posthumus, Silke, Otten, Antonius T., Dijkstra, Gerard, Kosterink, Jos G.W., Frijlink, Henderik W.
Zdroj: In Journal of Drug Delivery Science and Technology August 2021 64
Databáze: ScienceDirect